47 related articles for article (PubMed ID: 9128299)
1. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
2. Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children.
Cucchiara S; Franco MT; Terrin G; Spadaro R; di Nardo G; Iula V
Paediatr Drugs; 2000; 2(4):263-72. PubMed ID: 10946415
[TBL] [Abstract][Full Text] [Related]
3. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
Castell DO; Katz PO
Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
[No Abstract] [Full Text] [Related]
4. Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO
Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781
[TBL] [Abstract][Full Text] [Related]
5. Importance of adequate acid suppression in the management of Barrett's esophagus.
Castell DO; Katzka DA
Gastroenterology; 1999 Dec; 117(6):1509-10. PubMed ID: 10610344
[No Abstract] [Full Text] [Related]
6. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
[TBL] [Abstract][Full Text] [Related]
7. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: acid suppression, but no regression.
Bozymski EM; Shaheen NJ
Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
[No Abstract] [Full Text] [Related]
9. Reduction of acid exposure and regression of Barrett's esophagus.
Sampliner RE
Dig Dis; 2000-2001; 18(4):203-7. PubMed ID: 11356991
[TBL] [Abstract][Full Text] [Related]
10. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
11. Intravenous lansoprazole: in erosive oesophagitis.
Dando TM; Plosker GL
Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
[TBL] [Abstract][Full Text] [Related]
12. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
Miner P
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
